Riskpilot← Back to searchSign inGet full accessRosenbaum Medical AB
ABActiveOrg 5563324556Ormebäcksgatan 11 AHospital activities · NACE 8610Est. 19880 employees
Revenue 2024
SEK 0
EBITDA margin
—
+39% vs 2023
Equity ratio
79.3%
Financial strength
Net profit 2024
SEK -22K
+36% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -22K | +39% |
| Net profit | SEK -22K | +36% |
| Total assets | SEK 65K | -24% |
| Equity | SEK 52K | -30% |
| Employees | 0 | — |
Legal name
Rosenbaum Medical AB
Org number
5563324556
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
30 augusti 1988
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva konsultverksamhet inom sjukvård, uthyrning av läkare och annan sjukvårdspersonal, utbildning och pedagogiska uppdrag inom medicin och hälsa samt därmed likartad verksamhet. dessutom ska bolaget äga och förvalta värdepapper, lös och fast egendom samt därmed förenlig verksamhet.
Address
Ormebäcksgatan 11 A
Phone
+46131597000
Email
adamrosenbaum81@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 164 | 192 | 104 | 4 | 0 |
| Staff expenses | — | — | — | −0 | — |
| EBITDA | 114 | 138 | 35 | −36 | −22 |
| Depreciation & amort. | −0 | −0 | −0 | — | −1 |
| EBIT | 114 | 138 | 35 | −36 | −23 |
| Net financials | — | — | — | 1 | 1 |
| Profit before tax | 157 | 138 | 35 | −35 | −22 |
| Tax | −35 | −29 | −8 | — | — |
| Net profit | 122 | 109 | 27 | −35 | −22 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 247 | 233 | 158 | 86 | 65 |
| Equity | 223 | 212 | 139 | 74 | 52 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 24 | 21 | 19 | 12 | 14 |
| Total debt | 24 | 21 | 19 | 12 | 14 |
EBITDA margin
-2195400.0%
This company
15.8%
Market median
-13895037% vs market
20202024
Equity ratio
79.3%
This company
38.2%
Market median
+108% vs market
20202024
Return on equity
-42.9%
This company
18.4%
Market median
-333% vs market
20202024
Net profit margin
-2227200.0%
This company
8.1%
Market median
-27496396% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Deputy Board Member | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Rosenbaum Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Erik Rosenbaum | Deputy Board Member | 0 companies |
| Adam Leif Edvin Rosenbaum | Board of Directors | 0 companies |
| Sara Kristin Brandt Knutsson | Deputy Board Member | 0 companies |
| Annika Margareta Rosenbaum | Board of Directors | 0 companies |